References
- Bokarewa MI, Bremme K, Blombäck M. Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy. Br J Haematol. 1996;92:473–478.
- Greer IA, Aharon A, Brenner B, et al. Coagulation and placenta-mediated complications. Rambam Maimonides Med J. 2014;5:e0034.
- Rambaldi MP, Mecacci F, Guaschino S, et al. Inherited and acquired thrombophilias. Reprod Sci. 2014;21:167–182.
- Fogerty AE. Challenges of anticoagulation therapy in pregnancy. Curr Treat Options Cardiovasc Med. 2017;19:76.
- An J, Waitara MS, Bordas M, et al. Heparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model. Blood. 2013;121:2127–2134.
- Greer IA. Low molecular weight heparin for pregnancy complications? Thromb Res. 2009;123:S22–S25.
- Rodger MA, Betancourt MT, Clark P, et al. The association of factor V Leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PLoS Med. 2010;7:e1000292.
- Isermann B, Sood R, Pawlinski R, et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med. 2003;9:331–337.
- Pettilä V, Kaaja R, Leinonen P, et al. Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy. Thromb Res. 1999;96:275–282.
- Knol HM, Schultinge L, Veeger NJ, et al. The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy. Thromb Res. 2012;130:334–338.
- Lepercq J, Conard J, Borel-Derlon A, et al. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. BJOG. 2001;108:1134–1140.
- James AH. Prevention and treatment of venous thromboembolism in pregnancy. Clin Obstet Gynaecol. 2012;55:774–787.
- James AH. Pregnancy and thrombotic risk. Crit Care Med. 2010;38:S57–S63.
- Statistic data on pregnancies, deliveries and newborns; [cited 2018 Mar 14]. Available from: http://www.socialstyrelsen.se/statistik/statistikefteramne/graviditeter,forlossningarochnyfodda.
- Swedish Society for Obstetrics and Gynaecology. Hemostatic diseases in obstetrics and gynaecology. Working and reference group (ARG) report series; Report 79 (Swedish); 2018.
- Aboulghar M, Islam YY. Twin and preterm labor: prediction and treatment. Curr Obstet Gynecol Rep. 2013;2:232–239.
- Bain E, Wilson A, Tooher R, et al. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2014;2:CD001689.